These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 8572668

  • 1. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J.
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [Abstract] [Full Text] [Related]

  • 2. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F, van Walderveen M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1675-86. PubMed ID: 10603619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M, Grossman RI, Filippi M.
    J Neuroimaging; 2005 Oct 29; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [Abstract] [Full Text] [Related]

  • 6. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M.
    Brain; 2003 Oct 29; 126(Pt 10):2323-32. PubMed ID: 12937086
    [Abstract] [Full Text] [Related]

  • 7. Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force.
    Miller DH.
    Mult Scler; 1996 Jul 29; 1(6):335-8. PubMed ID: 9345412
    [Abstract] [Full Text] [Related]

  • 8. Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis.
    Rovaris M, Horsfield MA, Filippi M.
    Neurology; 1999 Jul 29; 53(5 Suppl 3):S40-5. PubMed ID: 10496210
    [Abstract] [Full Text] [Related]

  • 9. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 29; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 10. [Magnetic resonance imaging in multiple sclerosis].
    Saida T.
    Rinsho Shinkeigaku; 1999 Jan 29; 39(1):114-5. PubMed ID: 10377832
    [Abstract] [Full Text] [Related]

  • 11. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R, Leist TP.
    J Neuroimaging; 2005 Jan 29; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [Abstract] [Full Text] [Related]

  • 12. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
    Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH.
    Ann Neurol; 1998 Mar 29; 43(3):332-9. PubMed ID: 9506550
    [Abstract] [Full Text] [Related]

  • 13. MRI to monitor treatment efficacy in multiple sclerosis.
    Fazekas F, Soelberg-Sorensen P, Comi G, Filippi M.
    J Neuroimaging; 2007 Apr 29; 17 Suppl 1():50S-55S. PubMed ID: 17425736
    [Abstract] [Full Text] [Related]

  • 14. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 29; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R.
    J Neuroimaging; 2005 Aug 29; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [Abstract] [Full Text] [Related]

  • 16. Role of MRI in diagnosis and treatment of multiple sclerosis.
    Sahraian MA, Eshaghi A.
    Clin Neurol Neurosurg; 2010 Sep 29; 112(7):609-15. PubMed ID: 20417027
    [Abstract] [Full Text] [Related]

  • 17. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D.
    Neurology; 2011 Jan 04; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [Abstract] [Full Text] [Related]

  • 18. [Study with localized proton magnetic resonance spectroscopy of 31 multiple sclerosis lesions: correlations with clinical and MRI features].
    Viala K, Stievenart JL, Cabanis EA, Lyon-Caen O, Tourbah A.
    Rev Neurol (Paris); 2001 Jan 04; 157(1):35-44. PubMed ID: 11240546
    [Abstract] [Full Text] [Related]

  • 19. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 04; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 20. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
    Filippi M, Horsfield MA, Adèr HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH.
    Ann Neurol; 1998 Apr 04; 43(4):499-506. PubMed ID: 9546332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.